oncgnostics' Biz Plan Competition Round

oncgnostics raised a round of funding on December 09, 2011. Investors include Grunderpreis Thuringen.

oncgnostics aims at the identification and utilization of molecular markers for the early diagnosis of cervical cancer. The concept, applying tumor-specific DNA methylation markers for cancer diagnosi…

Articles about oncgnostics' Biz Plan Competition Round: